BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30515664)

  • 41. Haemophilia care in Europe: the ESCHQoL study.
    Schramm W; Gringeri A; Ljung R; Berger K; Crispin A; Bullinger M; Giangrande PL; Von Mackensen S; Mantovani LG; Nemes L; Serban M;
    Haemophilia; 2012 Sep; 18(5):729-37. PubMed ID: 22639833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation.
    Hay CRM; Xiang H; Scott M; Collins PW; Liesner R; Dolan G; Hollingsworth R
    Haemophilia; 2017 Sep; 23(5):728-735. PubMed ID: 28806858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do patients with haemophilia and von Willebrand disease with arterial hypertension have bleeding complications: a German single centre cohort.
    Alesci RS; Krekeler S; Seifried E; Miesbach W
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):320-3. PubMed ID: 22473050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres.
    Byams VR; Kouides PA; Kulkarni R; Baker JR; Brown DL; Gill JC; Grant AM; James AH; Konkle BA; Maahs J; Dumas MM; McAlister S; Nance D; Nugent D; Philipp CS; Soucie JM; Stang E;
    Haemophilia; 2011 Jul; 17 Suppl 1(0 1):6-13. PubMed ID: 21692922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Congenital bleeding disorders in Karachi, Pakistan.
    Borhany M; Shamsi T; Naz A; Khan A; Parveen K; Ansari S; Farzana T
    Clin Appl Thromb Hemost; 2011; 17(6):E131-7. PubMed ID: 21247962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A three-year study of adolescent boys suffering from haemophilia and allied disorders.
    Rainsford SG; Hall A
    Br J Haematol; 1973 May; 24(5):539-51. PubMed ID: 4541300
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibitor development in haemophilia according to concentrate. Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project.
    Fischer K; Lassila R; Peyvandi F; Calizzani G; Gatt A; Lambert T; Windyga J; Iorio A; Gilman E; Makris M;
    Thromb Haemost; 2015 May; 113(5):968-75. PubMed ID: 25567324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The World Federation of Hemophilia Annual Global Survey 1999-2018.
    Stonebraker JS; Bolton-Maggs PHB; Brooker M; Evatt B; Iorio A; Makris M; O'Mahony B; Skinner MW; Coffin D; Pierce GF; Tootoonchian E
    Haemophilia; 2020 Jul; 26(4):591-600. PubMed ID: 32497379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of hepatitis C virus infection among patients with inherited bleeding disorders in Newfoundland.
    Ali SK; Ozere R; Kutty KM; Richards H; Ratnam S; St Croix E; Bishai FR
    Can Commun Dis Rep; 1992 Jun; 18(12):91-2, 95. PubMed ID: 1299427
    [No Abstract]   [Full Text] [Related]  

  • 50. Inherited bleeding syndromes in Jordan.
    Alsabti EA; Hammadi M
    Acta Haematol; 1979; 61(1):47-51. PubMed ID: 105540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis and treatment challenges in lower resource countries: State-of-the-art.
    Mahlangu J; Diop S; Lavin M
    Haemophilia; 2024 Apr; 30 Suppl 3():78-85. PubMed ID: 38462793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haemophilia and allied disorders in the Sudan.
    Omer A; Ziada M
    Br J Haematol; 1973 Jul; 25(1):69-75. PubMed ID: 4545825
    [No Abstract]   [Full Text] [Related]  

  • 53. Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry.
    Fischer K; Ljung R; Platokouki H; Liesner R; Claeyssens S; Smink E; van den Berg HM
    Haemophilia; 2014 Jul; 20(4):e280-6. PubMed ID: 24784937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemophilia: provision of factors and novel therapies: World Federation of Hemophilia goals and achievements.
    Skinner MW
    Br J Haematol; 2011 Sep; 154(6):704-14. PubMed ID: 21707577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Choice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25).
    Meunier S; d'oiron R; Chambost H; Dolimier E; Guillet B;
    Thromb Res; 2017 Mar; 151():17-22. PubMed ID: 28088606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemophilia patients aged 0-18 years in the Western Cape.
    Hazewinkel MH; Hoogerwerf JJ; Hesseling PB; Hartley P; MacLean PE; Peters M; Wessels G
    S Afr Med J; 2003 Oct; 93(10):793-6. PubMed ID: 14652975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Rare bleeding disorders and invasive procedures].
    Bonhomme F; Schved JF; Giansily-Blaizot M; Samama CM; de Moerloose P
    Ann Fr Anesth Reanim; 2013 Mar; 32(3):198-205. PubMed ID: 23422342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.
    Osooli M; Steen Carlsson K; Astermark J; Berntorp E
    Haemophilia; 2017 Sep; 23(5):e403-e408. PubMed ID: 28758324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spectrum of inherited bleeding disorders from Western India.
    Manisha M; Ghosh K; Shetty S; Nair S; Khare A; Kulkarni B; Pathare AV; Baindur S; Mohanty D
    Haematologia (Budap); 2002; 32(1):39-47. PubMed ID: 12243554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.